

HY-175802 · 50 mg
MedChemExpress · Cat: HY-175802
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/hbi-2375.htmlDescription
HBI-2375 HYBI-084 is a selective, brain-penetrant and orally active MLL1-WDR5 interaction inhibitor. HBI-2375 inhibits WDR5 with an IC50 of 4.48 nM. HBI-2375 shows inhibition of proliferation in MV4;11 leukemia cells IC50: 3.17 AAasAasAAmuM . HBI-2375 is capable of targeted disruption of histone methyltransferase activity in cancer cells. HBI-2375 can be used for the study of leukemia, glioma and glioblastoma.